{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:34:37Z","timestamp":1789544077775,"version":"build-2803163510"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The large mortality and morbidity rate of <jats:italic>C. albicans<\/jats:italic> infections is a crucial problem in medical mycology. Because the generation of biofilms and drug resistance are growing concerns, the growth of novel antifungal agents and the looking for newer objectives are necessary. In this review, inhibitors of <jats:italic>C. albicans<\/jats:italic> biofilm generation and molecular mechanisms of intestinal epithelial barrier protection are elucidated. Recent studies on various transcription elements; quorum-sensing molecules; host responses to adherence; and changes in efflux pumps, enzymes, bud to hyphal transition, and lipid profiles have increased the knowledge of the intricate mechanisms underlying biofilm resistance. In addition, the growth of novel biomaterials with anti-adhesive nature, natural products, drugs, bioactive compounds, proteins, lipids, and carbohydrates are being researched. Recently, more and more attention has been given to various metal nanoparticles that have also appeared as antibiofilm agents in <jats:italic>C. albicans<\/jats:italic>. The intestinal epithelial obstacle exerts an crucial effect on keeping intestinal homeostasis and is increasingly associated with various disorders associated with the intestine such as inflammatory bowel disease (IBD), irritable bowel syndrome, metabolic syndrome, allergies, hepatic inflammation, septic shock, etc. However, whether their involvement in the prevention of other intestinal disorders like IBD are useful in <jats:italic>C. albicans<\/jats:italic> remains unknown. Further studies must be carried out in order to validate their inhibition functions in intestinal <jats:italic>C. albicans<\/jats:italic>. This provides innovates ideas for intestinal <jats:italic>C. albicans<\/jats:italic> treatment.<\/jats:p>","DOI":"10.3389\/fmicb.2021.783010","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:38:40Z","timestamp":1643780320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier"],"prefix":"10.3389","volume":"12","author":[{"given":"Ziyao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1128\/AAC.02659-15","article-title":"Sustained nitric oxide-releasing nanoparticles induce cell death in Candida albicans yeast and hyphal cells, preventing biofilm formation in vitro and in a rodent central venous catheter model.","volume":"60","author":"Ahmadi","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ibd.20413","article-title":"Hepatocyte nuclear factor 4 alpha in the intestinal epithelial cells protects against inflammatory bowel disease.","volume":"14","author":"Ahn","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans.","volume":"48","author":"Alem","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jof4040140","article-title":"The significance of lipids to biofilm formation in Candida albicans: an emerging perspective.","volume":"4","author":"Alim","year":"2018","journal-title":"J. Fungi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.","volume":"54","author":"Andes","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1439-0507.2004.01052.x","article-title":"Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.","volume":"48","author":"Arai","year":"2005","journal-title":"Mycoses"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.812","article-title":"RNA aptamers selected against yeast cells inhibit Candida albicans biofilm formation in vitro.","volume":"8","author":"Bachtiar","year":"2019","journal-title":"Microbiologyopen"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150457","article-title":"Streptococcus mutans can modulate biofilm formation and attenuate the virulence of Candida albicans.","volume":"11","author":"Barbosa","year":"2016","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75930-9","article-title":"Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface.","volume":"10","author":"Bauerl","year":"2020","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections.","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1038\/mi.2008.47","article-title":"Barrier-protective function of intestinal epithelial Toll-like receptor 2.","volume":"1","author":"Cario","year":"2008","journal-title":"Muc. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/11315520-000000000-00000","article-title":"Candidaemia in patients with an inserted medical device.","author":"Cauda","year":"2009","journal-title":"Drugs"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01750-17","article-title":"CD101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms.","volume":"62","author":"Chandra","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.","volume":"183","author":"Chandra","year":"2001","journal-title":"J. Bacteriol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/JVI.01754-14","article-title":"Chronic administration of Delta(9)-tetrahydrocannabinol induces intestinal anti-inflammatory MicroRNA expression during acute simian immunodeficiency virus infection of rhesus macaques.","volume":"89","author":"Chandra","year":"2015","journal-title":"J. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions.","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114201","article-title":"Perillaldehyde: a promising antifungal agent to treat oropharyngeal candidiasis.","volume":"180","author":"Chen","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1053\/j.gastro.2013.08.035","article-title":"Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection.","volume":"145","author":"Conway","year":"2013","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/pathogens3040908","article-title":"Antimicrobial and antibiofilm activity of chitosan on the oral pathogen Candida albicans.","volume":"3","author":"Costa","year":"2014","journal-title":"Pathogens"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections.","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1128\/AAC.03869-14","article-title":"Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.","volume":"58","author":"De Cremer","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1097\/mib.0000000000000204","article-title":"Intestinal inflammation and mucosal barrier function.","volume":"20","author":"de Medina","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12223-011-0049-6","article-title":"Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism.","volume":"56","author":"de Quadros","year":"2011","journal-title":"Folia Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1128\/AAC.03336-14","article-title":"Structure-activity relationship study of the plant-derived decapeptide osip108 inhibiting Candida albicans biofilm formation.","volume":"58","author":"Delattin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-80","article-title":"Human serum inhibits adhesion and biofilm formation in Candida albicans.","volume":"14","author":"Ding","year":"2014","journal-title":"BMC Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms.","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8030150","article-title":"Antifungal and antivirulence activity of vaginal Lactobacillus Spp. products against candida vaginal Isolates.","volume":"8","author":"dos Santos","year":"2019","journal-title":"Pathogens"},{"key":"B29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3920\/BM2016.0197","article-title":"Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells.","volume":"8","author":"Elce","year":"2017","journal-title":"Beneficial Microbes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00430-010-0169-7","article-title":"Effect of inhibitors of arachidonic acid metabolism on prostaglandin E2 production by Candida albicans and Candida dubliniensis biofilms.","volume":"200","author":"Ells","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10863-019-09817-4","article-title":"Farnesol contributes to intestinal epithelial barrier function by enhancing tight junctions via the JAK\/STAT3 signaling pathway in differentiated Caco-2 cells.","volume":"51","author":"Fang","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093225","article-title":"Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans.","volume":"9","author":"Feldman","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4161\/trns.22281","article-title":"A sticky situation: untangling the transcriptional network controlling biofilm development in Candida albicans.","volume":"3","author":"Fox","year":"2012","journal-title":"Transcription"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/489821","article-title":"How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology.","volume":"2015","author":"Frosali","year":"2015","journal-title":"J. Immunol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/1567-1364.12048","article-title":"Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers.","volume":"13","author":"Gao","year":"2013","journal-title":"FEMS Yeast Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"G1168","DOI":"10.1152\/ajpgi.00219.2004","article-title":"Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose.","volume":"287","author":"Gaudier","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-065X.2011.01078.x","article-title":"Epithelial barrier: an interface for the cross-communication between gut flora and immune system.","volume":"245","author":"Goto","year":"2012","journal-title":"Immunol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1073\/pnas.1620432114","article-title":"Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans.","volume":"114","author":"Graham","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: development, regulation, and molecular mechanisms.","volume":"18","author":"Gulati","year":"2016","journal-title":"Microbes Infect."},{"key":"B40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/mi.2010.76","article-title":"Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica.","volume":"4","author":"Guo","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep23575","article-title":"Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth.","volume":"6","author":"Haque","year":"2016","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IJN.S38708","article-title":"Bismuth oxide aqueous colloidal nanoparticles inhibit Candida albicans growth and biofilm formation.","volume":"8","author":"Hernandez-Delgadillo","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00405","article-title":"Physiological regulation of innate lymphoid cells.","volume":"10","author":"Jacquelot","year":"2019","journal-title":"Front. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1086\/652783","article-title":"Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.","volume":"201","author":"Katragkou","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/21505594.2020.1870082","article-title":"MSS2 maintains mitochondrial function and is required for chitosan resistance, invasive growth, biofilm formation and virulence in Candida albicans.","volume":"12","author":"Ke","year":"2021","journal-title":"Virulence"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01641","article-title":"Enhanced killing and antibiofilm activity of encapsulated cinnamaldehyde against Candida albicans.","volume":"8","author":"Khan","year":"2017","journal-title":"Front. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1214914","article-title":"Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles.","volume":"137","author":"Kiss","year":"2012","journal-title":"Immunology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01070","article-title":"Nuclear receptors regulate intestinal inflammation in the context of IBD.","volume":"10","author":"Klepsch","year":"2019","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/cmr.17.2.255-267.2004","article-title":"Candida infections of medical devices.","volume":"17","author":"Kojic","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133215","article-title":"Labetalol prevents intestinal dysfunction induced by traumatic brain injury.","volume":"10","author":"Lang","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02641","article-title":"Suppression of fluconazole resistant Candida albicans biofilm formation and filamentation by methylindole derivatives.","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.2187","article-title":"AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch.","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccc.2010.11.001","article-title":"Fungal sepsis: optimizing antifungal therapy in the critical care setting.","volume":"27","author":"Lepak","year":"2011","journal-title":"Crit. Care Clin."},{"key":"B54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11046-016-9997-3","article-title":"Nosocomial bloodstream infection due to Candida spp. in China: species distribution, clinical features, and outcomes.","volume":"181","author":"Li","year":"2016","journal-title":"Mycopathologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035543","article-title":"In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D.","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jsbmb.2015.01.011","article-title":"Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation.","volume":"148","author":"Li","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/icvts\/ivz147","article-title":"Cold-inducible RNA-binding protein maintains intestinal barrier during deep hypothermic circulatory arrest.","volume":"29","author":"Li","year":"2019","journal-title":"Int. Cardiovasc. Thorac. Surg."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02707-16","article-title":"In vitro antibiofilm activity of eucarobustol E against Candida albicans.","volume":"61","author":"Liu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01027","article-title":"Combination of antifungal drugs and protease inhibitors prevent Candida albicans biofilm formation and disrupt mature biofilms.","volume":"11","author":"Lohse","year":"2020","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrmicro.2017.107","article-title":"Development and regulation of single- and multi-species Candida albicans biofilms.","volume":"16","author":"Lohse","year":"2018","journal-title":"Nat. Revi. Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1469-0691.12042","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.","author":"Lortholary","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00544","article-title":"The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro.","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26390-w","article-title":"A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase.","volume":"12","author":"MacAlpine","year":"2021","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176755","article-title":"Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.","volume":"12","author":"Madariaga-Venegas","year":"2017","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01476","article-title":"Antibiofilm and antihyphal activities of cedar leaf essential oil, camphor, and fenchone derivatives against Candida albicans.","volume":"8","author":"Manoharan","year":"2017","journal-title":"Front. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/1751-7915.13268","article-title":"Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation.","volume":"11","author":"Manoharan","year":"2018","journal-title":"Microb. Biotechnol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/mmy\/myv028","article-title":"Study on the comparative activity of echinocandins on murine gut colonization by Candida albicans.","volume":"53","author":"Maraki","year":"2015","journal-title":"Med. Mycol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1128\/IAI.06140-11","article-title":"Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism.","volume":"80","author":"Marie","year":"2012","journal-title":"Infect. Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clini.Infect. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijantimicag.2009.04.011","article-title":"In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.","volume":"34","author":"Miceli","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jhin.2009.02.009","article-title":"Candida colonisation as a source for candidaemia.","volume":"72","author":"Miranda","year":"2009","journal-title":"J. Hosp. Infect."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55379-1","article-title":"Identification of a phenylthiazole small molecule with dual antifungal and antibiofilm activity against Candida albicans and Candida auris.","volume":"9","author":"Mohammad","year":"2019","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167470","article-title":"Inhibition of Candida albicans biofilm formation by the synthetic lactoferricin derived peptide hLF1-11.","volume":"11","author":"Morici","year":"2016","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1093\/jac\/dkr358","article-title":"Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages.","volume":"66","author":"Nguyen","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097864","article-title":"A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.","volume":"9","author":"Nieminen","year":"2014","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1128\/IAI.72.11.6206-6210.2004","article-title":"Regulation of Candida albicans morphogenesis by fatty acid metabolites.","volume":"72","author":"Noverr","year":"2004","journal-title":"Infect. Immun."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/cc436","article-title":"Fluconazole prophylaxis of systemic candida infection in non-neutropenic critically ill patients: a prospective randomized study.","author":"Parizkova","year":"1999","journal-title":"Crit. Care"},{"key":"B79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem.","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance.","volume":"1","author":"Pierce","year":"2015","journal-title":"Npj Biofilms Microbiomes"},{"key":"B81","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/2049-632X.12161","article-title":"High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.","volume":"70","author":"Pierce","year":"2014","journal-title":"Pathog Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1556\/030.62.2015.3.9","article-title":"Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014).","volume":"62","author":"Pongr\u00e1cz","year":"2015","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"B83","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","article-title":"The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.","volume":"36","author":"Qiu","year":"2012","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/10408410903241436","article-title":"Our current understanding of fungal biofilms.","volume":"35","author":"Ramage","year":"2009","journal-title":"Crit. Rev. Microbiol."},{"key":"B85","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update.","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryotic Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050758","article-title":"Antifungal and antibiofilm activities and the mechanism of action of repeating lysine-tryptophan peptides against Candida albicans.","volume":"8","author":"Ramamourthy","year":"2020","journal-title":"Microorganisms"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00730","article-title":"Alkylimidazolium ionic liquids as antifungal alternatives: antibiofilm activity against Candida albicans and underlying mechanism of action.","volume":"11","author":"Reddy","year":"2020","journal-title":"Front. Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1128\/AAC.00190-16","article-title":"Exploiting interkingdom interactions for development of small-molecule inhibitors of Candida albicans biofilm formation.","volume":"60","author":"Reen","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/myc.12147","article-title":"Effects of ambroxol on Candida albicans growth and biofilm formation.","volume":"57","author":"Rene","year":"2014","journal-title":"Mycoses"},{"key":"B90","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1567-1364.2009.00504.x","article-title":"Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.","volume":"9","author":"Ricardo","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01400-4","article-title":"Tumor necrosis factor prevents Candida albicans biofilm formation.","volume":"7","author":"Rocha","year":"2017","journal-title":"Sci. Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The toll-like receptor 2 Pathway establishes colonization by a commensal of the human microbiota.","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/jac\/dkz280","article-title":"In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.","volume":"74","author":"Rudramurthy","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e00689","DOI":"10.1128\/mSphere.00689-20","article-title":"Bacteria modify Candida albicans hypha formation, microcolony properties, and survival within macrophages.","volume":"5","author":"Salvatori","year":"2020","journal-title":"mSphere"},{"key":"B95","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1017\/S0007114512004035","article-title":"Host-microbe interactions: the difficult yet peaceful coexistence of the microbiota and the intestinal mucosa.","author":"S\u00e1nchez de Medina","year":"2013","journal-title":"Br. J. Nutr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1093\/emboj\/18.17.4657","article-title":"Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis.","volume":"18","author":"Sano","year":"1999","journal-title":"EMBO J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature21080","article-title":"Feedback control of AHR signalling regulates intestinal immunity.","volume":"542","author":"Schiering","year":"2017","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJGM.S38065","article-title":"Assessment of the types of catheter infectivity caused by Candida species and their biofilm formation. First study in an intensive care unit in Algeria.","volume":"6","author":"Seddiki","year":"2013","journal-title":"Int. J. Gen. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2008.04.020","article-title":"Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.","volume":"135","author":"Shang","year":"2008","journal-title":"Gastroenterology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/srep08131","article-title":"Using Bayesian modelling to investigate factors governing antibiotic-induced Candida albicans colonization of the GI tract.","volume":"5","author":"Shankar","year":"2015","journal-title":"Sci. Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2567.2008.02847.x","article-title":"Prostaglandin E(2) and Kruppel-like transcription factors synergistically induce the expression of decay-accelerating factor in intestinal epithelial cells.","volume":"125","author":"Shao","year":"2008","journal-title":"Immunology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.1007\/s00253-016-7619-0","article-title":"Fermented Yupingfeng polysaccharides enhance immunity by improving the foregut microflora and intestinal barrier in weaning rex rabbits.","volume":"100","author":"Sun","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00451","article-title":"MicroRNA Post-transcriptional regulation of the NLRP3 Inflammasome in Immunopathologies.","volume":"10","author":"Tezcan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050866","article-title":"Purpurin suppresses Candida albicans biofilm formation and hyphal development.","volume":"7","author":"Tsang","year":"2012","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000828","article-title":"Dispersion as an important step in the Candida albicans biofilm developmental cycle.","volume":"6","author":"Uppuluri","year":"2010","journal-title":"PLoS Pathog."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1128\/AAC.01701-10","article-title":"Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.","volume":"55","author":"Uppuluri","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cellsig.2017.04.007","article-title":"Activation of muscarinic receptors prevents TNF-alpha-mediated intestinal epithelial barrier disruption through p38 MAPK.","volume":"35","author":"Uwada","year":"2017","journal-title":"Cell. Signal."},{"key":"B109","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ijantimicag.2016.07.022","article-title":"Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells.","volume":"48","author":"Vila","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211366","article-title":"Metagenomic quorum quenching enzymes affect biofilm formation of Candida albicans and Staphylococcus epidermidis.","volume":"14","author":"Weiland-Brauer","year":"2019","journal-title":"PLoS One"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","article-title":"Nosocomial candidemia: risk factors and attributable mortality.","volume":"20","author":"Wenzel","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01394-19","article-title":"Disparate Candida albicans biofilm formation in clinical lipid emulsions due to capric acid-mediated inhibition.","volume":"63","author":"Willems","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jcmgh.2020.06.011","article-title":"Proline-rich acidic protein 1 (PRAP1) protects the gastrointestinal epithelium from irradiation-induced apoptosis.","volume":"10","author":"Wolfarth","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/08927014.2017.1295304","article-title":"In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.","volume":"33","author":"Xia","year":"2017","journal-title":"Biofouling"},{"key":"B116","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/cmi.12216","article-title":"Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response.","volume":"16","author":"Xu","year":"2014","journal-title":"Cell Microbiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.micres.2013.02.008","article-title":"Disruption of the intestinal mucosal barrier in Candida albicans infections.","volume":"168","author":"Yan","year":"2013","journal-title":"Microbiol. Res."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01085","article-title":"Effect of shikonin against Candida albicans Biofilms.","volume":"10","author":"Yan","year":"2019","journal-title":"Front. Microbiol."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-01850-3","article-title":"The effects of clioquinol in morphogenesis, cell membrane and ion homeostasis in Candida albicans.","volume":"20","author":"You","year":"2020","journal-title":"BMC Microbiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.biochi.2015.11.028","article-title":"Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms.","volume":"121","author":"Yu","year":"2016","journal-title":"Biochimie"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1016\/j.yexcr.2006.06.023","article-title":"LPS\/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3.","volume":"312","author":"Yu","year":"2006","journal-title":"Exp. Cell Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1515\/znb-2018-0225","article-title":"Synthesis of novel 1,2,3-triazole-substituted tomentosins.","volume":"74","author":"Zaki","year":"2019","journal-title":"ZNaturforsch"},{"key":"B123","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01333-14","article-title":"Novel entries in a fungal biofilm matrix encyclopedia.","volume":"5","author":"Zarnowski","year":"2014","journal-title":"mBio"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00323-20","article-title":"Interplay between Candida albicans and lactic acid bacteria in the gastrointestinal tract: impact on colonization resistance, microbial carriage, opportunistic infection, and host immunity.","volume":"34","author":"Zeise","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028953","article-title":"Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.783010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:38:44Z","timestamp":1643780324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.783010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":126,"alternative-id":["10.3389\/fmicb.2021.783010"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.783010","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"article-number":"783010"}}